Skip to content

Medical-device intelligence

LAS: Drug Specific Control Materials

FDA product code LAS: Drug Specific Control Materials. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
LAS
FDA device name
Drug Specific Control Materials
Device class
1
Regulation number
862.3280
Medical specialty
Clinical Toxicology
Review panel
TX

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore clinical toxicology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

83 clearance records and 1 recall records in the covered releases, across 28 source company names and 1 product codes. Dated history runs from Oct 7, 1976 to Oct 3, 2013.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
LAS · Drug Specific Control Materials831

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

84 matching records
Device / recordCompany in FDA recordSourceSource date
ABUSCREEN(R) ONLINE CONTROLSK910689 · LASRoche Diagnostic Systems, Inc.510(k)Mar 11, 1991FDA decision date
ABUSCREEN POSITIVE REFERENCE CONTROLSK894464 · LASRoche Diagnostic Systems, Inc.510(k)Aug 28, 1989FDA decision date
ABUSCREEN TRI-LEVEL REFERENCE CONTROLSK894463 · LASRoche Diagnostic Systems, Inc.510(k)Aug 21, 1989FDA decision date
ABUSCREEN ONTRAK POS. REF. CONTROL FOR BARBITUATESK893855 · LASRoche Diagnostic Systems, Inc.510(k)Aug 3, 1989FDA decision date
ABUSCREEN ONTRAK POS. REF. CONTROL FOR MORPHINEK893856 · LASRoche Diagnostic Systems, Inc.510(k)Aug 3, 1989FDA decision date
ABUSCREEN ONTRAK POS. REF. CONTROL FOR AMPHETAMINEK893857 · LASRoche Diagnostic Systems, Inc.510(k)Aug 3, 1989FDA decision date
ABUSCREEN ONTRAK POS. REFERENCE CONTROL FOR THCK893858 · LASRoche Diagnostic Systems, Inc.510(k)Aug 3, 1989FDA decision date
ABUSCREEN ONTRAK POS. REF. CONTROL FOR COCAINEK893859 · LASRoche Diagnostic Systems, Inc.510(k)Aug 3, 1989FDA decision date
ABUSCREEN ONTRAK POS.REF.CONTROL FOR PHENCYCLIDINEK893860 · LASRoche Diagnostic Systems, Inc.510(k)Aug 3, 1989FDA decision date
LIQUICHEK(R) SERUM ALCOHOL CONTROL; LEVELS 1,2 & 3K892004 · LASBio-Rad510(k)Apr 21, 1989FDA decision date
DU PONT DIMENSION PSEUDOCHOLINESTERASE VERIFIERK883891 · LASE.I. Dupont DE Nemours & Co., Inc.510(k)Nov 29, 1988FDA decision date
QUANTIMETRIX SERUM ALCOHOL CONTROL LEVEL 1 AND 2K873011 · LASQuantimetrix Medical Industries510(k)Oct 29, 1987FDA decision date
DIGOXIN FPIA CONTROLSK872347 · LASSigma Diagnostics, Inc.510(k)Jul 7, 1987FDA decision date
PHENYTOIN FPIA CONTROLSK871567 · LASSigma Diagnostics, Inc.510(k)Jul 1, 1987FDA decision date
CYCLOSPORIN A (WHOLE BLOOD) CONTROL - LEVELS 1,2,3K864456 · LASCala Diagnostics510(k)May 6, 1987FDA decision date
BENZODIAZEPINES TOXICOLOGY CONTROLK862418 · LASUtak Laboratories, Inc.510(k)Nov 13, 1986FDA decision date
SERUM VANCOMYCIN TOXICOLOGY CONTROLK862419 · LASUtak Laboratories, Inc.510(k)Nov 13, 1986FDA decision date
SERUM CLONAZEPAM TOXICOLOGY CONTROLK862421 · LASUtak Laboratories, Inc.510(k)Nov 5, 1986FDA decision date
HIGH PERFORMANCE CANNABINOID CONTROLSK863117 · LASRapid Diagnostic Laboratories, Inc.510(k)Sep 25, 1986FDA decision date
EMIT CAFFEINE CONTROLK861511 · LASSyva / A Syntex Co.510(k)Jun 13, 1986FDA decision date
EMIT 700 CANNABINOID CONTROL SETK843419 · LASSyva Co.510(k)Oct 5, 1984FDA decision date
ACA TRICYCLIC ANTIDEPRESSANTS SCREENK841533 · LASE.I. Dupont DE Nemours & Co., Inc.510(k)May 11, 1984FDA decision date
MAPROTILINEK831735 · LASUtak Laboratories, Inc.510(k)Jul 26, 1983FDA decision date
CAFFINE TOXICOLOGY CONTROLK831738 · LASUtak Laboratories, Inc.510(k)Jul 26, 1983FDA decision date
EMIT SERUM TRICYCLIC ANTIDEPRESS. CONTROK831979 · LASSyva Co.510(k)Jul 19, 1983FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗